You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞寶藥業(600351.SH):2021年度淨利預增53.68%-76.96%
格隆匯 01-18 15:50

格隆匯1月18日丨亞寶藥業(600351.SH)公佈2021年年度業績預增公吿,公司預計2021年年度實現歸屬於上市公司股東的淨利潤為1.65億元到1.9億元,與上年同期相比將增加5763.09萬元到8263.09萬元,同比增加53.68%到76.96%。

預計公司2021年年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤為1.35億元到1.598億元,與上年同期相比將增加7290.24萬元到9790.24萬元,同比增加117.85%到158.26%。

業績預增的主要原因:

(一)主營業務影響

2021年度,公司聚焦高毛利核心產品並加大推廣力度,丁桂兒臍貼、消腫止痛貼、薏芽健脾凝膠及兒童清咽解熱口服液等高毛利產品收入均取得較大增長,促使公司2021年度經營業績大幅增長。

(二)上年比較基數較小

因為疫情影響,公司2020年歸屬於上市公司股東的淨利潤基數較小,使得本期業績較上年同期增長幅度較大。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account